RGEN RSI Chart
Last 7 days
4.3%
Last 30 days
-5.0%
Last 90 days
8.4%
Trailing 12 Months
14.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 777.8M | 729.3M | 669.8M | 638.8M |
2022 | 734.1M | 778.8M | 801.3M | 801.5M |
2021 | 433.0M | 508.5M | 592.7M | 670.5M |
2020 | 285.7M | 302.5M | 327.1M | 366.3M |
2019 | 209.8M | 232.8M | 252.7M | 270.2M |
2018 | 155.5M | 170.8M | 183.7M | 194.0M |
2017 | 110.0M | 113.3M | 125.2M | 141.2M |
2016 | 87.8M | 95.5M | 100.4M | 104.5M |
2015 | 66.9M | 72.8M | 77.5M | 83.5M |
2014 | 66.0M | 64.1M | 60.4M | 60.4M |
2013 | 65.9M | 67.9M | 71.6M | 68.2M |
2012 | 36.3M | 44.1M | 50.6M | 62.3M |
2011 | 27.3M | 27.9M | 29.3M | 29.4M |
2010 | 21.0M | 22.6M | 24.1M | 25.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 18, 2024 | pax margaret | acquired | - | - | 92.00 | - |
Mar 18, 2024 | hunt anthony | gifted | - | - | -2,000 | chief executive officer |
Mar 11, 2024 | kuriyel ralf | sold | -681,348 | 193 | -3,517 | senior vp, r&d |
Mar 11, 2024 | kuriyel ralf | acquired | 109,433 | 86.1 | 1,271 | senior vp, r&d |
Mar 08, 2024 | hunt anthony | sold | -3,298,630 | 197 | -16,707 | chief executive officer |
Mar 08, 2024 | hunt anthony | acquired | 16.55 | 16.55 | 1.00 | chief executive officer |
Mar 07, 2024 | bylund james | sold (taxes) | -236,038 | 195 | -1,206 | chief operating officer |
Mar 07, 2024 | hunt anthony | sold (taxes) | -561,129 | 195 | -2,867 | chief executive officer |
Mar 07, 2024 | gebski christine | sold (taxes) | -75,547 | 195 | -386 | see remarks |
Mar 07, 2024 | kuriyel ralf | sold (taxes) | -75,547 | 195 | -386 | senior vp, r&d |
Which funds bought or sold RGEN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 26, 2024 | Fairman Group, LLC | new | - | 1,438 | 1,438 | -% |
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -11.84 | -2,607 | 820,428 | -% |
Mar 15, 2024 | B. Riley Wealth Advisors, Inc. | reduced | -11.17 | 1,049 | 231,582 | 0.01% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.66 | 110,889,000 | 913,077,000 | 0.02% |
Mar 04, 2024 | CONGRESS ASSET MANAGEMENT CO /MA | added | 220 | 10,003,200 | 13,808,600 | 0.11% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 75.8 | 47,082,600 | 94,745,100 | 0.01% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -3.99 | 997,937 | 12,654,300 | 0.05% |
Feb 26, 2024 | Neo Ivy Capital Management | new | - | 164,000 | 164,000 | 0.37% |
Feb 26, 2024 | Virtu Financial LLC | reduced | -60.68 | -268,000 | 215,000 | 0.02% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -4.53 | 223,000 | 3,031,000 | 0.03% |
Unveiling Repligen Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to Repligen Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 196.9B | 40.1B | 34.4 | 4.91 | ||||
BDX | 71.2B | 19.5B | 56.69 | 3.65 | ||||
ALGN | 24.6B | 3.9B | 55.33 | 6.38 | ||||
BAX | 21.7B | 14.8B | 8.16 | 1.46 | ||||
MID-CAP | ||||||||
BIO | 10.2B | 2.7B | -16.04 | 3.83 | ||||
HSIC | 9.7B | 12.3B | 23.21 | 0.78 | ||||
ATR | 9.5B | 3.5B | 33.57 | 2.74 | ||||
XRAY | 6.9B | 4.0B | -51.36 | 1.74 | ||||
AXNX | 3.5B | 366.4M | -577.22 | 9.59 | ||||
PDCO | 2.5B | 6.6B | 12.86 | 0.38 | ||||
SMALL-CAP | ||||||||
AHCO | 1.5B | 3.2B | -2.23 | 0.47 | ||||
ANIK | 379.3M | 166.7M | -4.59 | 2.28 | ||||
ANGO | 227.2M | 329.5M | -16.09 | 0.69 | ||||
APYX | 43.3M | 52.3M | -2.31 | 0.83 | ||||
AEMD | 4.5M | 3.7M | -0.37 | 1.19 |
Repligen Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 10.3% | 156 | 141 | 159 | 183 | 187 | 201 | 208 | 206 | 187 | 178 | 163 | 143 | 109 | 94.00 | 87.00 | 76.00 | 69.00 | 69.00 | 71.00 | 61.00 | 52.00 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 60.00 | 54.00 | 51.00 | 44.00 | 39.00 | 38.00 | 40.00 | 34.00 | 28.00 |
Costs and Expenses | 14.8% | 157 | 136 | 140 | 151 | 138 | 148 | 144 | 146 | 149 | 133 | 115 | 106 | 91.00 | 73.00 | 68.00 | 64.00 | 64.00 | 61.00 | 60.00 | 49.00 | 44.00 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.00 | 73.00 | 68.00 | 64.00 | 64.00 | 61.00 | 60.00 | 49.00 | 44.00 |
S&GA Expenses | 3.7% | 58.00 | 55.00 | 49.00 | 56.00 | 53.00 | 54.00 | 55.00 | 54.00 | 52.00 | 48.00 | 44.00 | 39.00 | 36.00 | 29.00 | 27.00 | 28.00 | 28.00 | 25.00 | 24.00 | 19.00 | 17.00 |
R&D Expenses | -2.8% | 10.00 | 11.00 | 10.00 | 12.00 | 11.00 | 10.00 | 10.00 | 12.00 | 9.00 | 9.00 | 8.00 | 8.00 | 7.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 |
EBITDA Margin | -26.8% | 0.21* | 0.29* | 0.52* | 0.80* | 1.31* | 0.31* | 0.32* | 0.31* | 0.30* | 0.30* | 0.30* | 0.28* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 323.0% | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 |
Income Taxes | 356.8% | 17.00 | -6.50 | 5.00 | 7.00 | 4.00 | 7.00 | 10.00 | 12.00 | 6.00 | 8.00 | 8.00 | 4.00 | -4.92 | 3.00 | 0.00 | 1.00 | 1.00 | 0.00 | 2.00 | 2.00 | 1.00 |
Earnings Before Taxes | -175.3% | -8.76 | 12.00 | 25.00 | 36.00 | 53.00 | 47.00 | 60.00 | 59.00 | 35.00 | 41.00 | 44.00 | 33.00 | 15.00 | 18.00 | 16.00 | 11.00 | 4.00 | 2.00 | 10.00 | 11.00 | 7.00 |
EBT Margin | -46.6% | 0.10* | 0.19* | 0.38* | 0.62* | 1.06* | 0.25* | 0.25* | 0.24* | 0.23* | 0.23* | 0.22* | 0.19* | - | - | - | - | - | - | - | - | - |
Net Income | -240.3% | -25.49 | 18.00 | 20.00 | 29.00 | 49.00 | 40.00 | 50.00 | 47.00 | 29.00 | 33.00 | 36.00 | 29.00 | 20.00 | 15.00 | 16.00 | 10.00 | 4.00 | 2.00 | 8.00 | 8.00 | 6.00 |
Net Income Margin | -62.4% | 0.07* | 0.17* | 0.33* | 0.53* | 0.90* | 0.21* | 0.20* | 0.20* | 0.19* | 0.20* | 0.20* | 0.18* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -41.7% | 18.00 | 31.00 | 26.00 | 3.00 | 41.00 | 30.00 | 20.00 | -4.09 | 18.00 | 12.00 | 21.00 | 2.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 12.3% | 2,824 | 2,514 | 2,549 | 2,538 | 2,525 | 2,463 | 2,445 | 2,384 | 2,358 | 2,241 | 2,016 | 1,927 | 1,903 | 1,476 | 1,442 | 1,406 | 1,400 | 1,379 | 1,068 | 798 | 775 |
Current Assets | 13.6% | 1,111 | 978 | 999 | 1,019 | 998 | 953 | 976 | 945 | 932 | 911 | 984 | 926 | 902 | 697 | 687 | 651 | 642 | 622 | 316 | 284 | 276 |
Cash Equivalents | 19.1% | 751 | 631 | 604 | 517 | 523 | 573 | 597 | 585 | 604 | 621 | 734 | 711 | 717 | 553 | 560 | 539 | 537 | 522 | 218 | 196 | 194 |
Inventory | -4.3% | 202 | 211 | 241 | 245 | 238 | 243 | 239 | 214 | 184 | 156 | 136 | 110 | 95.00 | 79.00 | 70.00 | 62.00 | 55.00 | 52.00 | 51.00 | 45.00 | 42.00 |
Net PPE | 2.9% | 207 | 202 | 203 | 193 | 191 | 174 | 168 | 148 | 125 | 100 | 85.00 | 72.00 | 67.00 | 55.00 | 52.00 | 50.00 | 48.00 | 43.00 | 38.00 | 35.00 | 32.00 |
Goodwill | 13.6% | 987 | 869 | 871 | 856 | 856 | 851 | 854 | 859 | 860 | 834 | 618 | 618 | 618 | 482 | 13.00 | 468 | 468 | 469 | 470 | 326 | 327 |
Liabilities | 62.3% | 853 | 526 | 578 | 598 | 614 | 627 | 640 | 617 | 608 | 526 | 413 | 371 | 374 | 351 | 342 | 337 | 340 | 334 | 189 | 173 | 159 |
Current Liabilities | -56.5% | 158 | 363 | 374 | 405 | 404 | 411 | 424 | 424 | 375 | 349 | 332 | 313 | 319 | 51.00 | 44.00 | 42.00 | 48.00 | 39.00 | 141 | 130 | 130 |
Long Term Debt | - | 510 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | 510 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -0.9% | 1,971 | 1,989 | 1,971 | 1,940 | 1,911 | 1,835 | 1,805 | 1,766 | 1,750 | 1,715 | 1,603 | 1,556 | 1,529 | 1,125 | 1,100 | 1,070 | 1,060 | 1,045 | 879 | 625 | 616 |
Retained Earnings | -5.5% | 439 | 464 | 446 | 426 | 397 | 349 | 308 | 258 | 194 | 165 | 131 | 95.00 | 66.00 | 46.00 | 32.00 | 16.00 | 6.00 | 2.00 | 1.00 | -7.51 | -0.68 |
Additional Paid-In Capital | 0.1% | 1,569 | 1,567 | 1,561 | 1,545 | 1,547 | 1,541 | 1,534 | 1,529 | 1,572 | 1,560 | 1,475 | 1,468 | 1,461 | 1,088 | 1,082 | 1,074 | 1,068 | 1,064 | 893 | 646 | 643 |
Shares Outstanding | 0.0% | 56.00 | 56.00 | 56.00 | 56.00 | 56.00 | 56.00 | 55.00 | 55.00 | 55.00 | 55.00 | 55.00 | 55.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 6,932 | - | - | - | 8,912 | - | - | - | 10,858 | - | - | - | 5,712 | - | - | - | 3,600 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -25.9% | 29,065 | 39,231 | 34,468 | 11,154 | 61,882 | 41,367 | 45,721 | 23,113 | 49,620 | 22,483 | 37,651 | 9,262 | 14,871 | 21,489 | 16,735 | 9,530 | 17,674 | 21,965 | 17,789 | 9,788 | 5,555 |
Share Based Compensation | 1.4% | 6,465 | 6,373 | 5,483 | 7,254 | 6,262 | 6,154 | 6,985 | 7,915 | 7,020 | 6,800 | 7,143 | 6,541 | 4,529 | 4,200 | 4,100 | 4,165 | 3,389 | 3,175 | 3,031 | 3,251 | 2,520 |
Cashflow From Investing | -1837.3% | -169,905 | -8,770 | 64,833 | -9,433 | -121,308 | -57,494 | -26,220 | -28,214 | -62,276 | -132,695 | -17,201 | -8,997 | -158,288 | -33,580 | -4,480 | -5,037 | -7,111 | -6,892 | -187,477 | -3,828 | -5,457 |
Cashflow From Financing | 34563.6% | 268,127 | -778 | -8,825 | -9,563 | -274 | 1,251 | -2,293 | -12,021 | 231 | -122 | 345 | 507 | 298,838 | 1,676 | 3,813 | 1,589 | -180 | 294,875 | 190,128 | 44.00 | 1,044 |
Buy Backs | - | - | - | - | - | - | - | - | - | -330 | - | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 12 Months Ended | |||||
---|---|---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | ||||
Revenue: | ||||||
Revenue | $ 638,764 | $ 801,536 | $ 670,534 | |||
Costs and operating expenses: | ||||||
Cost of product revenue | 353,922 | 345,830 | 279,280 | |||
Research and development | 42,722 | 43,936 | 34,274 | |||
Selling, general and administrative | 218,113 | 215,829 | 183,866 | |||
Contingent consideration | (30,569) | (28,729) | 5,865 | |||
Total costs and operating expenses | 584,188 | 576,866 | 503,285 | |||
Income from operations | 54,576 | 224,670 | 167,249 | |||
Other income (expenses): | ||||||
Investment income | 24,135 | 6,978 | 176 | |||
Interest expense | (1,951) | (1,162) | (11,278) | |||
Loss on extinguishment of debt | (12,676) | 0 | 0 | |||
Amortization of debt issuance costs | (8,075) | (1,815) | (1,436) | |||
Other income (expenses) | 8,123 | (9,531) | (1,168) | |||
Other income (expenses), net | 9,556 | (5,530) | (13,706) | |||
Income before income taxes | 64,132 | 219,140 | 153,543 | |||
Income tax provision | 22,555 | 33,181 | 25,252 | |||
Net income | $ 41,577 | $ 185,959 | $ 128,291 | |||
Earnings per share: | ||||||
Basic | $ 0.75 | $ 3.35 | $ 2.33 | |||
Diluted | $ 0.74 | $ 3.24 | $ 2.24 | |||
Weighted average common shares outstanding: | ||||||
Basic | 55,720 | 55,460 | 55,015 | |||
Diluted | 56,377 | 57,455 | 57,264 | |||
Net Income (Loss) | $ 41,577 | $ 185,959 | $ 128,291 | |||
Other comprehensive income (loss): | ||||||
Foreign currency translation adjustment | (3,037) | (17,508) | (18,971) | |||
Comprehensive income | 38,540 | 168,451 | 109,320 | |||
Products | ||||||
Revenue: | ||||||
Revenue | 638,381 | [1] | 801,183 | 670,319 | ||
Royalty and Other Revenue | ||||||
Revenue: | ||||||
Revenue | $ 383 | $ 353 | $ 215 | |||
|
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 751,323 | $ 523,458 |
Marketable securities held to maturity | 0 | 100,299 |
Accounts receivable, net of reserves of $2,122 and $1,365 at December 31, 2023 and December 31, 2022, respectively | 124,161 | 116,247 |
Inventories, net | 202,321 | 238,277 |
Prepaid expenses and other current assets | 33,238 | 19,837 |
Total current assets | 1,111,043 | 998,118 |
Property, plant and equipment, net | 207,440 | 190,673 |
Intangible assets, net | 400,486 | 353,676 |
Goodwill | 987,120 | 855,513 |
Deferred tax assets | 1,530 | 840 |
Operating lease right of use assets | 115,515 | 125,023 |
Other noncurrent assets | 1,277 | 815 |
Total noncurrent assets | 1,713,368 | 1,526,540 |
Total assets | 2,824,411 | 2,524,658 |
Current liabilities: | ||
Accounts payable | 19,563 | 27,554 |
Operating lease liability | 5,631 | 6,957 |
Current contingent consideration | 12,983 | 13,950 |
Accrued liabilities | 50,533 | 71,120 |
Convertible Senior Notes due 2024, net | 69,452 | 284,615 |
Total current liabilities | 158,162 | 404,196 |
Convertible Senior Notes due 2028, net | 510,143 | 0 |
Deferred tax liabilities | 40,466 | 23,000 |
Noncurrent operating lease liability | 126,578 | 131,389 |
Noncurrent contingent consideration | 14,070 | 51,559 |
Other noncurrent liabilities | 3,789 | 3,814 |
Total noncurrent liabilities | 695,046 | 209,762 |
Total liabilities | 853,208 | 613,958 |
Commitments and contingencies (Note 13) | ||
Stockholders' equity: | ||
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued or outstanding | 0 | 0 |
Common stock, $0.01 par value; 80,000,000 shares authorized; 55,766,078 shares at December 31, 2023 and 55,557,698 shares at December 31, 2022 issued and outstanding | 558 | 556 |
Additional paid-in capital | 1,569,227 | 1,547,266 |
Accumulated other comprehensive loss | (37,431) | (34,394) |
Accumulated earnings | 438,849 | 397,272 |
Total stockholders' equity | 1,971,203 | 1,910,700 |
Total liabilities and stockholders' equity | $ 2,824,411 | $ 2,524,658 |
 | Mr. Anthony J. Hunt |
---|---|
 | www.repligen.com |
 | 2025 |